Back to Trades
O'Byrne Jason
EVP & Chief Financial OfficerCIK 0001871145
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
O'Byrne Jason, EVP & Chief Financial Officer, accounts for 4 disclosed filings worth $900.5K, all concentrated in Vir Biotechnology, Inc. (VIR), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $68.9K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Mar 23 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Other | $0 |
| Feb 26 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Sell | $15.6K |
| Feb 24 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Sell | $15.6K |
| Nov 18 | VIR Vir Biotechnology, Inc. | O'Byrne Jason | EVP & Chief Financial Officer | Sell | $37.8K |
4 filings